https://www.selleckchem.com/pr....oducts/thal-sns-032.
5%) of the current cohort. Suboptimal platelet response to DAPT was associated with a significantly greater extent of MVO when expressed as a percentage of the left ventricular mass, left ventricular scar, and the number of myocardial left ventricular segments showing MVO (P less then 0.01 for each). Adjusted multivariable logistic regression model revealed that suboptimal response to DAPT is significantly associated with both greater late gadolinium enhancement (P less then 0.01) and MVO extent (odds ratio, 3.7 [95% CI, 1.3-10.5];